You have no items in your shopping cart.
Laboratory research use only. Not for human or animal consumption.

GH / Hormone Review

View as Grid List
Sort by
CJC-1295

CJC-1295

A growth-hormone releasing hormone analog commonly reviewed for GH pulse support.

GHRecovery
More library details

Research context

  • Extends growth-hormone releasing hormone signaling depending on form.
  • Often paired with a GHRP such as ipamorelin.

Review before use

  • Review IGF-1, glucose, sleep apnea risk, cancer history, and edema symptoms.
  • Clarify DAC versus no-DAC form before any protocol discussion.

Evidence notes

  • GH-axis compounds are discussed around growth-hormone and GHRH signaling and require lab-guided review.
  • Evidence and risk review should include IGF-1, glucose, edema, sleep apnea, and cancer-history considerations.

Cautions

  • Hormone-pathway agents need lab monitoring.
  • Avoid if contraindicated by personal cancer risk or unmanaged metabolic disease.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$35.00
Ipamorelin

Ipamorelin

A growth-hormone secretagogue often discussed as a cleaner GH pulse option than older GHRPs.

SleepGH
More library details

Research context

  • Stimulates GH release through ghrelin receptor signaling.
  • Commonly reviewed with CJC-1295 for recovery and sleep-focused protocols.

Review before use

  • Review appetite, glucose, IGF-1, and sleep apnea considerations.
  • Confirm timing and whether it conflicts with nutrition schedule.

Evidence notes

  • GH secretagogue research focuses on ghrelin-receptor signaling and growth-hormone pulse support.
  • Risk review should include appetite, glucose, IGF-1, edema, sleep apnea, and hormone-sensitive history.

Cautions

  • Not appropriate for unsupervised hormone manipulation.
  • Discuss swelling, tingling, glucose issues, and headache symptoms.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$28.00
Sermorelin

Sermorelin

A GHRH analog used in some clinics for growth-hormone stimulation review.

GHSleep
More library details

Research context

  • Supports endogenous GH signaling rather than replacing GH.
  • Often evaluated through IGF-1 and symptom tracking.

Review before use

  • Review baseline labs, sleep apnea, glucose control, and expected monitoring schedule.
  • Compare with CJC/ipamorelin options with a clinician.

Evidence notes

  • GHRH analog research and clinical use focus on endogenous growth-hormone stimulation under medical review.
  • Monitoring commonly centers on IGF-1, sleep apnea risk, glucose, edema, and expected clinical goals.

Cautions

  • Hormone-axis protocols require medical supervision.
  • Do not use with unexplained symptoms or active malignancy concerns.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$43.00
Kisspeptin-10

Kisspeptin-10

A reproductive-axis peptide discussed for LH/FSH signaling and hormone evaluation.

HormoneFertility
More library details

Research context

  • Stimulates upstream reproductive hormone signaling.
  • Reviewed in testosterone, fertility, and reproductive-axis contexts.

Review before use

  • Review LH, FSH, testosterone, estradiol, fertility goals, and medications.
  • Clarify whether symptoms are thyroid, sleep, stress, or gonadal-axis related.

Cautions

  • Requires lab-guided medical oversight.
  • Do not combine with hormone therapy without clinician review.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$40.00
CJC-1295 + Ipamorelin

CJC-1295 + Ipamorelin

A common GH-support stack pairing GHRH signaling with GH secretagogue pulse support.

GHRecovery
More library details

Research context

  • Combines upstream GH-releasing support with pulse stimulation.
  • Often reviewed for sleep, recovery, lean mass, and body composition.

Review before use

  • Review labs, cancer risk, glucose, sleep apnea, edema, and protocol duration.
  • Clarify timing around meals and sleep.

Evidence notes

  • This stack combines GHRH analog and GH secretagogue concepts, so monitoring should follow GH-axis risk review.
  • Evidence and risk review should include IGF-1, glucose, edema, sleep apnea, and cancer-history considerations.

Cautions

  • Requires clinician oversight and lab monitoring.
  • Avoid stacking with other GH/IGF agents casually.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$56.00

FOR RESEARCH USE ONLY. The products offered on this site are intended solely for in-vitro laboratory research and development use. These statements and products have not been evaluated by the U.S. Food and Drug Administration (FDA). These products are not drugs, foods, dietary supplements, or cosmetics, and are not intended to diagnose, treat, cure, or prevent any disease or medical condition. They are not intended for human or animal consumption, ingestion, injection, or any in-vivo or clinical use of any kind. By purchasing from RevPep, you confirm that you are a qualified researcher or institution and that you will handle, store, and dispose of these materials in accordance with all applicable laws, regulations, and institutional safety protocols.